IMPORTANCE Data are sparse regarding which blood pressure (BP) components in young adulthood optimally determine cardiovascular disease (CVD) by middle age.
Y ounger adults (≤50 years of age) are increasingly prone to stroke, chronic kidney disease, and worsening cardiovascular disease (CVD) mortality. [1] [2] [3] [4] An alarming increase in the prevalence of high blood pressure (BP) in young adulthood may underlie these adverse trends. 5, 6 However, which specific BP components in young adulthood may optimally identify cardiovascular outcomes by middle age and whether these associations vary by race and age at BP measurement are poorly understood. Existing studies have found that the BP components that best identify CVD risk vary by age at BP measurement. In the Framingham Heart Study (FHS) 7, 8 and other studies with largely white study populations, [9] [10] [11] [12] among those younger than 50 years at BP measurement, diastolic BP (DBP) was a stronger indicator of incident CVD, whereas systolic BP (SBP) dominated at older ages. As a result, national guidelines encourage DBP as a treatment target in young adults. 13 However, observations in those aged 18 to 30 years are sparse, and whether these results are consistent across race groups is unknown. Given the earlier development of hypertension and arterial stiffness in black compared with white adults, [14] [15] [16] we hypothesized that SBP instead of DBP would be more strongly associated with CVD risk in black individuals, even at a young age. Using data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, which enrolled black and white adults in young adulthood and followed them up for 28 years, we assessed which BP components best identified incident CVD events and whether these associations varied by race and age at BP measurement.
Methods
The CARDIA study recruited patients from January 1, 1985, through December 31, 1986, enrolling 5115 black and white adults 18 to 30 years old (eMethods in the Supplement). 
BP and Other Measurements
From the Y 0 to Y 15 examinations, trained research staff measured brachial artery BP 3 times at 1-minute intervals after the participant had been sitting in a quiet room for 5 minutes, using a random-zero sphygmomanometer (Hawksley) . 18 The details are described in the eMethods in the Supplement. The mean of the second and third measurements was used for the analysis. The BP components evaluated included SBP, DBP, mean arterial pressure (MAP), mid-BP, and pulse pressure (PP). The MAP was defined as (SBP + 2 × DBP)/3. The PP was defined as SBP − DBP. Mid-BP, calculated as (SBP + DBP)/2, was highly correlated with MAP (r = 0.99; P < .001); thus, we only report MAP. Hypertension was defined as an SBP of 140 mm Hg or higher, a DBP of 90 mm Hg or higher, or use of antihypertensive medication. 13 Data on educational level, smoking, medication use, A Priori Diet Quality Score, clinical history of CVD, and fasting laboratory values were collected using standardized protocols and quality control procedures across study centers (eMethods in the Supplement).
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Cardiovascular Outcomes
We recorded incident CVD events through September 31, 2013, by scheduled study examinations and yearly telephone interviews (eMethods in the Supplement). Composite CVD included coronary heart disease, hospitalization for heart failure, stroke, transient ischemic attack, intervention for peripheral artery disease, or death from cardiovascular causes. [19] [20] [21] Participants who did not have events and who did not drop out of the study were censored at 28 years after the Y 0 examination.
Statistical Analysis
Our analyses were performed with 2 approaches (Figure 1 ). In the first analysis, we examined the associations between BP components at Y 0 and incident CVD events experienced throughout the entire follow-up period. The CVD events were ascertained annually during a 28-year follow-up period. Using Cox proportional hazards models, we first estimated racespecific multivariable-adjusted hazard ratios (HRs) and 95% CIs of incident CVD associated with each BP component. The proportionality assumption for the Cox analyses was confirmed graphically and with the inclusion of a time by BP component interaction. All BP components were analyzed per 1 SD to allow for direct comparison among components. Covariates included the sociodemographic characteristics of age, sex, educational level, and study site and the clinical characteristicsatY 0 of smoking, body mass index (BMI), fasting glucose level, total cholesterol and high-density lipoprotein cholesterol levels, and antihypertensive medication use. These co-
Key Points
Question Which blood pressure components best determine incident premature cardiovascular events in young adults and does the association vary by race and age at blood pressure measurement?
Findings This community-based cohort of 4880 young adults at baseline followed up for up to 28 years observed that in young adults (mean age, 25 years) systolic blood pressure is the most robust indicator of premature cardiovascular disease risk in black individuals, whereas diastolic blood pressure performed better than systolic blood pressure in determining premature cardiovascular disease in white individuals. In middle-aged adults (mean age, 40 years), systolic blood pressure instead of diastolic blood pressure better determined incident cardiovascular disease in both races.
Meaning Our data question the classic view that diastolic blood pressure more often identifies cardiovascular disease events than systolic blood pressure in all individuals younger than 50 years.
teraction between each BP component and race in association with incident CVD were performed with inclusion of multiplicative interaction terms. The likelihood ratio χ 2 , Akaike information criterion (AIC), and Bayes information criterion (BIC) estimates were used to assess model fit. Comparison of the discriminative ability of each model was conducted by Harrell C statistics (with 95% CIs, calculated by bootstrapping) as described by Newson. 23 In sensitivity analyses, we examined the following: (1) the interaction between sex or baseline antihypertensive medication use and each BP component in association with CVD risk; (2) the Y 0 BP-CVD risk association by excluding participants taking antihypertensive medications at Y 0 ; (3) whether the Y 0 BP-CVD risk association is modified by an adjustment for the A Priori Diet Quality Score; and (4) quartile analyses of BP.
In the second analysis, we examined the associations between BP components at Y 15 and incident CVD events experienced after the Y 15 examination. The rationale in selecting Y 15 BP to represent middle age includes the following: (1) age distribution at Y 15 (ie, 33 to 45 years of age) is separate from that at Y 0 (18 to 30 years of age); (2) because CARDIA follow-up extends for 30 years at this point, use of follow-up after Y 15 bisects the follow-up interval; and (3) the number of clinical events experienced after the Y 20 examination was half as many as after the Y 15 examination. We excluded those who had a CVD event or were censored before the Y 15 examination. We used clinical characteristics at Y 15 as covariates, in which we imputed missing data using multiple imputation chained equations with 20 iterations as described by Raghunathan et al 24 (eFigure 1 in the Supplement). We then followed them up until they developed CVD or were censored. Time-to-event methods were used based on the Cox proportional hazards models with the time defined as the number of days from the Y 15 examination to the first diagnosis of CVD events. All statistical analyses were performed with STATA software, version 12.1 (StataCorp). Statistical significance was defined as P < .05 using 2-sided tests.
Results
BP Measured at Y 0 and CVD Risk
A total of 4880 participants participated in the study (mean [SD] age, 24.9 [3.6] in black individuals than white individuals at Y 0 , but the DBP was similar between races. The distribution of SBP and DBP at Y 0 according to race is shown in eFigure 2 in the Supplement. In both races, male sex and higher BMI were associated with higher SBP, DBP, and MAP (eTable 1 and eTable 2 in the Supplement). The correlation between SBP and DBP is similar overall between black and white individuals (eTable 1 in the Supplement).
eFigure 3 in the Supplement shows the cause-specific incidence rate of cardiovascular outcomes, and the racespecific Kaplan-Meier cumulative incidence of CVD is shown in eFigure 4 in the Supplement. In black individuals, during a median follow-up of 24.5 years (49 201 person-years) (interquartile range [IQR] , 15.7-25.0 years), 140 CVD events occurred (2.85 per 1000 person-years; 95% CI, 2.41-3.36). In white individuals, 70 CVD events occurred (1.37 per 1000 personyears; 95% CI, 1.09-1.73) during a median follow-up of 24.7 years (51 039 person-years) (IQR, 20.1-25.0). All CVD events occurred before 58 years of age.
With adjustments for covariates, results from Cox proportional hazards models suggested that both SBP and DBP, when considered alone, were positively associated with CVD risk in black individuals, whereas only DBP was associated in white individuals ( Table 2) . When SBP and DBP were considered jointly, SBP but not DBP retained statistical significance in black individuals, whereas DBP but not SBP was associated with CVD risk in white individuals. When MAP and PP were analyzed jointly, MAP was consistently associated with CVD in both races. Results were similar when A Priori Diet Quality Score was included as an adjustment factor (eTable 3 in the Supplement). In race-combined analyses, significant interactions were found between race and SBP (P = .02) and PP (P = .02) but not DBP (P = .052).
The Y 0 BP component demonstrating the best model fit (ie, likelihood ratio χ 2 , AIC, and BIC) and discriminative ability (ie, C statistic) to identify incident CVD was SBP in black individuals and DBP in white individuals (Table 2 ). These indexes were not improved when combining SBP with DBP in either race.
In both races, there was no evidence of interaction between each BP component and sex or baseline antihypertensive medication use in association with CVD risk. We repeated Cox proportional hazards analyses in those without receiving hypertensive medication at Y 0 , and results were similar (eTable 4intheSupplement). Quartile analyses observed that, using a reference of the first quartile group of SBP (<105 mm Hg), CVD risk in the highest quartile group (SBP ≥119 mm Hg) was significant in black individuals but not in white individuals. The CVD risk in the highest quartile group of DBP (≥75 mm Hg), compared with the reference group (DBP <63 mm Hg), was significant in white individuals but not in black individuals (Figure 2) .
BP Measured at Y 15 and CVD Risk
Of the 4967 participants included in the analysis on baseline BP (Y 0 ) values, we excluded 87 participants who had a CVD event and 803 who were censored before the Y 15 examination. Among the 4077 remaining participants, 3547 attended the Y 15 examination, of whom 3534 had BP measurements. We imputed BP measurements for the 13 participants who attended the Y 15 examination and who had no BP measurement and for the 530 participants who did not attend the Y 15 examination but had at least 1 follow-up contact after the Y 15 examination, leaving a sample of 4077 participants for analysis. Their mean (SD) age was 40.2 (3.6) years, 56% were women, and 49% were black (eTable 5 in the Supplement). Approximately 8% of the entire cohort and 46% of patients with hypertension reported using antihypertensive medications. Mean (SD) BP using imputation was similar to that without imputation (eTable 6 in the Supplement). In black individuals, during a median follow-up of 9.7 years (16 241 person-years) (IQR, 5.6-10.0 years), 87 CVD events occurred (5.36 per 1000 personyears; 95% CI, 4.34-6.61). In white individuals, 44 CVD events occurred (2.49 per 1000 person-years; 95% CI, 1.86-3.35) during a median follow-up of 9.8 years (17 639 person-years) (IQR, 5.9-10.1 years). Results from Cox proportional hazards models suggested that SBP was consistently associated with CVD risk in both races when SBP and DBP were considered singly and jointly (Table 3) , whereas the association of DBP with CVD incidence was attenuated with adjustment for SBP. The PP was positively associated with CVD risk in black individuals only.
Results were similar when we excluded those receiving hypertensive medication at Y 15 (eTable 7 in the Supplement). Analyses without imputing missing BP at Y 15 (n = 3534) had similar results (eTable 8 in the Supplement).
Discussion
In this community-based cohort of young adults at baseline followed up for up to 28 years, BP components that best indicated CVD risk varied by race and age. Twice as many premature (before 58 years of age) CVD events occurred in black individuals compared with white individuals. In young adults with a mean age of 25 years (at Y 0 ), SBP was the most robust indicator of premature CVD risk in blacks, whereas DBP performed better than SBP in identifying premature CVD in white individuals. Young black adults with prehypertensive SBP levels are at increased risk for CVD events, independent of their DBP levels. Conversely, white individuals with prehypertensive DBP levels are at increased risk for CVD events, independent of their SBP levels. However, the C statistic change by adding SBP to the base model was modest with wide range in whites, which may be partly because of their low number of events. Whether SBP can best indicate incident CVD events in whites at approximately 40 years of age will need to be confirmed in larger studies or cohorts. C statistic changes by adding SBP at Y 0 to base models in black adults or by adding DBP in white adults were nonsignificant. However, these changes were statistically significant but modest in those who were not taking antihypertensive medication. This finding suggests that (1) the discriminative ability of BP might be affected by the presence of medication use, (2) large HRs (or relative risks) are required to achieve clinically meaningful C statistic change, 34 and (3) there was a narrow distribution of BP at Y 0 in this young healthy adult population. 35 Discrimination overall is better in whites than blacks across all models. Traditional risk factors appear to be less predictive of premature CVD in blacks than whites. Even when the HRs are similar in blacks and whites, racial differences in the prevalence of risk factors can affect variables for model selection. This finding may contribute to differences in the overall performance of the risk model when it is applied to blacks vs whites.
Strengths and Limitations
Strengths of this study include the large, community-based biracial cohort; adjudication of suspected cardiovascular outcomes by a panel of physicians using detailed evaluation criteria; high retention; and the standardized data collection protocols and rigorous quality control in CARDIA. All events were premature CVD events, an important measure of a population's health but often understudied in older cohorts. However, there are limitations. First, possible residual confounding may be affecting the BP-CVD risk associations. Sodium intake may be one such example. Although a high A Priori Diet Quality Score tends to indicate lower sodium intake, the score itself cannot capture individual sodium intake well. Second, participants taking antihypertensive medication were included, which 
Conclusions
Our data question the classic view that DBP is more predictive of CVD events than SBP in all individuals younger than 50 years. [8] [9] [10] [11] [12] [13] Arterial aging is a complex and heterogeneous process beginning early in life 27, 38 ; thus, one size may not fit all in the clinical management of BP for young adults. Different BP components reflect distinctive hemodynamics [25] [26] [27] ; therefore, refining BP components associated with CVD could lead to an optimization of diagnostic and therapeutic strategies. Specifically, for young black adults with high SBP, therapeutic strategies aimed at improving or slowing aortic stiffness, such as lifestyle changes, including dietary interventions (eg, reducing salt and weight loss) and using renin-angiotensinaldosterone system inhibitors, may be beneficial in preventing premature CVD events. [39] [40] [41] In contrast, for young white adults with high DBP, therapeutic strategies aimed at reducing peripheral vascular resistance (eg, exercise and using calcium channel blockers) may be efficacious. 42, 43 The hypothesis will need to be confirmed in interventional trials, with consideration of all the complex issues at play, including costeffectiveness, utility (including potential adverse events), and patient perspectives.
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On one hand, our knowledge of hypertension has exploded in the century since Korotokoff's publication. Researchers have unraveled a number of the physiological processes associated with hypertension, including the interplay between the kidneys, vasculature, and nervous system. In addition, large epidemiological studies have demonstrated clear associations between elevated systolic BP (SBP), diastolic BP (DBP), and pulse pressure and subsequent damage to the heart, brain, and kidneys. Closing the loop, multiple clini-4. Measurement: staff inflated the cuff to the R-Z peak inflation level, holding the pressure constant with the bulb (wait 5 seconds), placed the bell of stethoscope on the brachial artery, and slowly deflated the cuff (2 mmHg per second). Staff recorded the 1 st and 5 th Korotkoff sounds, reading the pressure in mmHg to the nearest even number and recording it.
5. Caffeine, eating, heavy physical activity, smoking, and alcohol intake were proscribed for two hours prior to BP recording.
6. BP measures were made before the physical examination, blood drawing, treadmill test, or any stressful interview.
7. BP measures were made in a separate room, or at minimum, in an area properly screened from all other activity and other participants.
At each examination, research staff measured right-arm brachial artery BP 3 times after the participant had been sitting in a quiet room for 5 minutes. Three measurements were taken at 1-minute interval, and the average of the 2 nd and 3 rd measurements was used for the analysis of office BP. Information on smoking status, education, and blood analysis was collected via standardized protocols and quality control across study centers. Current smoking status was defined as current, former, or never by self-report.
The A Priori Diet Quality Score (APDQS), which has been validated by demonstrating its association with cardiovascular risk, [3] [4] [5] [6] was assessed at Y 0 . Details of the APDQS been described previously. [3] [4] [5] [6] Briefly, interviewers asked open-ended questions about dietary consumption in the past month within 100 food categories that referenced 1609 separate food items. Foods were assigned in one of 166 food groups using the food-grouping system devised by the University of Minnesota Nutrition Coordinating Center.
Food-group intake was assessed as servings per day of constituent foods. We created a dietary pattern score from the 46 foods groups as conducted in previous studies. [3] [4] [5] [6] The theoretical maximum score was 132. A higher APDQS indicates better diet quality.
Cardiovascular outcomes
We recorded incident cardiovascular disease (CVD) events through September, 2013.
During their scheduled study examinations and yearly telephone interviews, each participant or designated proxy was asked about interim hospital admissions, outpatient procedures, and deaths. Medical records were requested for participants who had been hospitalized or received an outpatient revascularization procedure.
Vital status was assessed every 6 months; medical/death records were requested after consent had been obtained from the participants or next of kin. Two physician members of the Endpoints Committee independently reviewed medical records to adjudicate each possible CVD event or underlying cause of death using specific definitions and a detailed manual of operations (http://www.cardia.dopm.uab.edu).
If disagreement occurred between the primary reviewers, the case was reviewed by the full committee. Coronary heart disease (CHD) included hospitalization for myocardial infarction, acute coronary syndrome with or without evidence of myocardial necrosis, coronary artery revascularization, or CHD death (including fatal myocardial infarction). CVD included CHD, and hospitalization for heart failure (HF), stroke, transient ischemic attack, intervention for peripheral artery disease, or death from cardiovascular causes.
Definitions of each outcome have been previously described. Race-specific cumulative incidence rate of cardiovascular disease (CVD) events is shown.
CVD included coronary heart disease, stroke, transient ischemic attack, heart failure, and other vascular diseases. The definition of each color line is as follows: black line, blacks; gray line, whites. The log-rank was used to calculate P value. 
